SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...


Founded in 2021, 5Metis is a pure‐play discovery agrichemical company resulting from the union of the former Boragen, Inc. and AgriMetis, LLC agrichemical platforms. The company is focused on the discovery of new molecules with novel modes of action by combining boron‐based small molecule discovery and natural product synthetic biology.